黑色素瘤中的免疫调节和免疫治疗:重点关注CD155信号的审查
Li-Ying Wu1,2,3, Su-Ho Park2,3, Haakan Jakobsson4
1School of Biomedical Sciences, Faculty of Health, Queensland University of Technology, Brisbane, QLD 4059, Australia.
Cancers
|June 19, 2024
概括
黑色素瘤免疫疗法显示出有希望的结果,但患者的益处各不相同. 了解免疫调节和CD155的理解
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 皮肤病学 皮肤病学
背景情况:
- 黑色素瘤是癌症死亡的重要原因,特别是在年轻人群中.
- 免疫疗法是晚期黑色素瘤的主要治疗方法,因为它具有很高的免疫性.
- 患者对免疫疗法的多样性反应凸显了理解黑色素瘤瘤微环境的挑战.
研究的目的:
- 审查当前的抗黑色素瘤免疫治疗策略.
- 阐明免疫细胞子集在黑色素瘤中的作用.
- 探索CD155及其受体对黑色素瘤免疫反应的影响.
主要方法:
- 对抗黑色素瘤免疫疗法的综合文献综述.
- 免疫细胞贡献的分析 (瘤内皮细胞,骨髓细胞衍生的抑制细胞,细胞毒性T细胞,与癌症相关的纤维细胞,NK细胞).
- 在黑色素瘤瘤微环境中检查CD155,DNAM-1,TIGIT和CD96相互作用.
主要成果:
- CD155的过度表达与黑色素瘤的免疫调节和治疗耐药性有关.
- 目前的免疫疗法会以不同的方式影响各种免疫细胞子集.
- CD155及其受体在调节对黑色素瘤的免疫反应中起着至关重要的作用.
结论:
- 更深入地了解黑色素瘤瘤微环境中的免疫调节对于患者分层至关重要.
- 准CD155及其通路为新型抗癌免疫疗法提供了潜在的战略.
- 进一步研究CD155的作用对于改善黑色素瘤治疗结果至关重要.
更多相关视频
09:53Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens
Published on: February 6, 2017
11.4K
12:16A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells
Published on: October 16, 2018
14.7K
相关概念视频
Tumor Immunotherapy
511
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
511
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
T Cell Types and Functions
999
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
999
